Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Germany.
J Thorac Cardiovasc Surg. 2012 Jul;144(1):166-72. doi: 10.1016/j.jtcvs.2011.12.020. Epub 2012 Jan 12.
The Norwood procedure, the first surgical step of staged palliation for hypoplastic left heart syndrome, is also applied for other complex single-ventricle lesions with systemic outflow tract obstruction or aortic arch hypoplasia. We reviewed our 15-year institutional experience with the Norwood procedure for patients with and without hypoplastic left heart syndrome.
A total of 41 patients without hypoplastic left heart syndrome and 212 patients with hypoplastic left heart syndrome who underwent a Norwood procedure between January 1996 and December 2010 were enrolled. Full medical records were reviewed to assess the determinants of outcome.
Early failure (death or cardiac transplantation) was 7% in patients without hypoplastic left heart syndrome and 13% in patients with hypoplastic left heart syndrome (P = .29). Frequency of postoperative complications, duration of postoperative ventilation, and length of vasoactive drug treatment were not different between groups. Transplant-free survival until the second operative step trended to be higher for patients without hypoplastic left heart syndrome (92% vs 80%, P = .067). Recurrent aortic arch obstruction was more common in patients without hypoplastic left heart syndrome (15/39 vs 32/171, P = .008), but there were 4 patients with stenosis of the proximal aortic arch. In subsequent procedures, 31 patients without hypoplastic left heart syndrome underwent superior cavopulmonary anastomosis and 5 biventricular repair. Overall transplant-free survival was not different between groups (P = .119) but trended to be higher in patients with a systemic or substantial left ventricle remnant contributing to cardiac output (P = .082).
Early and long-term survivals and postoperative complications were similar between patients with and without hypoplastic left heart syndrome undergoing a Norwood operation. Recurrent aortic arch obstruction was common in both groups but more prevalent in patients without hypoplastic left heart syndrome.
诺伍德手术是左心发育不全综合征分期姑息治疗的第一步,也适用于其他伴有体肺流出道梗阻或主动脉弓发育不良的复杂单心室病变。我们回顾了我们机构 15 年来对患有和不患有左心发育不全综合征的患者进行诺伍德手术的经验。
共纳入 41 例不伴有左心发育不全综合征和 212 例伴有左心发育不全综合征的患者,他们在 1996 年 1 月至 2010 年 12 月期间接受了诺伍德手术。回顾了完整的病历,以评估结果的决定因素。
不伴有左心发育不全综合征的患者早期失败(死亡或心脏移植)的发生率为 7%,伴有左心发育不全综合征的患者为 13%(P=.29)。两组术后并发症的发生率、术后通气时间和血管活性药物治疗时间无差异。无左心发育不全综合征患者的无移植存活至第二次手术阶段的趋势较高(92%比 80%,P=.067)。不伴有左心发育不全综合征的患者中,主动脉弓再梗阻更为常见(15/39 比 32/171,P=.008),但有 4 例近端主动脉弓狭窄。在随后的手术中,31 例不伴有左心发育不全综合征的患者行上腔静脉-肺动脉吻合术,5 例行双心室修复术。两组之间的无移植总体存活率无差异(P=.119),但在心脏输出量有系统或实质性左心室残端的患者中,存活率有升高趋势(P=.082)。
接受诺伍德手术的伴有和不伴有左心发育不全综合征的患者的早期和长期存活率及术后并发症相似。两组均有主动脉弓再梗阻,但不伴有左心发育不全综合征的患者更为常见。